DIN 02213826 — REVIA 50 MG
REVIA is a tablet of Naltrexone marketed by TEVA CANADA LIMITED. The full Naltrexone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02213826
- Brand name
- REVIA
- Active ingredient
- Naltrexone
- Strength
- 50 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Opioid antagonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Naltrexone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02444275 | APO-NALTREXONE | 50 MG | TABLET | APOTEX INC | MARKETED |
| 02451883 | NALTREXONE HYDROCHLORIDE TABLETS USP | 50 MG | TABLET | STERINOVA INC. | MARKETED |